REPATHA evolocumab (rch) 140 mg/mL injection solution syringe

Amgen Australia Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 1ed84f2462830004
Product Name: REPATHA evolocumab (rch) 140 mg/mL injection solution syringe
Artg Id: 231151
Artg Name: REPATHA evolocumab (rch) 140 mg/mL injection solution syringe
Sponsor: Amgen Australia Pty Ltd
Company Detail Path: /organization/amgen-australia-pty-ltd
Artg Date: 2015-12-09
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Product Information: https://medical-cdn.nocode.com/drug_tga/de0e5ab92a5811514383dae8f0f63a34.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

1ed84f2462830004

Type

Standard